|
- Pioneering AI Drug Discovery | Recursion
Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly optimized molecules that fuel our pipeline of potential first-in-class and best-in-class medicines
- Recursion Pharmaceuticals, Inc.
By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine
- Recursion Pharmaceuticals, Inc. - Recursion and Exscientia, two leaders . . .
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs
- Recursions Pipeline - AI in Pharma and BioTech | Recursion
As a leading drug discovery and development company, leveraging the power of the Recursion OS (our AI drug discovery platform) and a unique TechBio approach, we are building an industry-leading pipeline of best-in-class and first-in-class therapeutic assets
- Partners - Recursion
Technology, data, and capability partners In May 2024, Recursion entered into a multi-year agreement with Helix to access hundreds of thousands of de-identified records including Helix’s Exome+® genomic data and data from longitudinal health records
- Recursion Pharmaceuticals, Inc. - Preliminary Phase 1b 2 Data for REC . . .
Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias
- Careers at Recursion: Join Our Mission | Recursion
Embark on a career journey with Recursion Dive into opportunities, culture, and the impact you can make Apply to work with us today!
- Press Releases Recursion News | Recursion
Stay updated with the latest press releases and news from Recursion Dive into our achievements, announcements, and more Explore now!
|
|
|